In line with this concept, polymorphisms in human genes encoding the mineralocorticoid (MR) and glucocorticoid receptor (GR) were found to be associated with depression and altered hypothalamic–pituitary–adrenal (HPA) axis function [53]. This evidence concerns the gene NR3C1 and depressive symptom measurement.